bodySCULPT® has some exciting news to share!

Click to Learn More

bodySCULPT Surgeons at the Plastic Surgery The Meeting 2024

This past weekend, from September 26 to 29, 2024, in San Diego, Dr. Christopher Chia had the privilege of attending Plastic Surgery The Meeting, hosted by the American Society of Plastic Surgeons (ASPS).

Plastic Surgery The Meeting is now even more accessible with on-demand sessions available. The on-demand sessions give participants the opportunity to watch lectures and instructional sessions whenever it’s most convenient for them. They are accessible from September 19 through December 31, 2024. On September 19, 2024, there was an educational on-demand lecture by Dr. Spero Theodorou titled “The ABCs of Anesthesia in Body Contouring: How Far Can We Go with as Little as Possible”. With this session, participants gained a greater awareness regarding how less aggressive forms of anesthesia can be effectively applied.

bodySCULPT Surgeons at the Plastic Surgery The Meeting 2024

Aman New York Secures Finalist Position in Destination Deluxe Awards

Aman New York has been named a finalist in three categories of Destination Deluxe Awards – Urban Wellness Retreat of the Year, Medi-Spa of the Year, and Medi-Spa Treatment of the Year. These awards honor leaders and pioneers in the wellness and travel sectors, celebrating those who drive luxury standards in these industries. Aman New York along with bodySCULPT Wellness and Aesthetics, is recognized for its dedication to providing comprehensive wellness programs, and combining medical expertise with a serene spa environment. This recognition underscores Aman New York’s commitment to excellence and innovation in wellness and hospitality.

Impact of Injectables in Future Facelift Surgeries

A recent Allure article explores the complexities faced by plastic surgeons when performing facelift procedures due to the effects of prior injectable treatments.  Dr. Theodorou’s insights highlight the critical importance of precise application of radiofrequency energy to avoid adverse effects. He also recommends dissolving the filler before surgery to minimize these risks. Although previous procedures are irreversible, careful consideration of treatment options can enhance the safety and efficacy of future facelifts.

Aman New York Ranked as One of the Top 5 Spas by Vogue

Aman New York has been recognized as one of NYC’s top 5 spas by Vogue Global Spa Guide. This luxurious spa offers the ultimate urban retreat.  The guide explains that stepping into Aman New York is like entering a spaceship bound for planet Luxury, with its perfectly designed lobby and calming eucalyptus scent creating an oasis amidst Manhattan’s chaos. The spa’s Asian minimalist aesthetic and expansive 25,000-square-foot space offer a haven for relaxation, featuring double treatment rooms, private yoga studios, and serene outdoor terraces with plunge pools. Aman’s commitment to sustainability shines through its use of vegan, cruelty-free products and recyclable packaging.

Discover why Vogue loves Aman New York!

Aman New York Ranked as One of the Top 5 Spas by Vogue

Dr. Spero Theodorou Will Discuss InMode Technologies at the Jefferies Healthcare Conference

bodySCULPT® plastic surgeon Dr. Spero Theodorou will be representing InMode at the prestigious Jefferies Healthcare Conference in New York. This event will provide valuable insights regarding InMode’s innovative medical technologies and strategic vision for the future.  Yair Malca, InMode’s Chief Financial Officer will also present in-person at this event. The fireside chat will be moderated by Matt Taylor, Managing Director, Senior Healthcare Analyst, and is scheduled for 7:30 am Eastern Time on Wednesday, June 5, 2024.

InMode will also hold one-on-one investor meetings in person that same day. Please contact your Jefferies representative if you want to schedule a meeting.

InMode Morpheus8 Partnering with P1 Offshore Racing for the UIM Class 1 World Championship

InMode Ltd. the manufacturer of Morpheus8, an innovative radiofrequency-powered microneedling aesthetic device and other advanced medical technologies is partnering with P1 Offshore Racing.  This move marks the first collaboration of an aesthetic company in offshore racing. The event will be held from May 17 – 19 at Coco Beach. InMode will sponsor the only female driver Victoria Rand.  It shows InMode’s dedication to empowering and championing women in all walks of life. Stressing the fact that when you look and feel your best, you are unstoppable, Dr. Spero Theodorou, MD said that Victoria Rand and the Morpheus8 Offshore Racing Team embody all of these values. The event is a true test of spirit and perseverance, and InMode is elated to sponsor a female driver who is a trailblazer.

InMode has been introducing technological advancements for more than two decades now and continues to break boundaries in aesthetics. Their aim is to enable women to live their most beautiful lives. Victoria Rand expressed her excitement regarding the partnership, seeing it as an opportunity to inspire women to be bold and confident in the racing world.

InMode Morpheus8 Partnering with P1 Offshore Racing for the UIM Class 1 World Championship

Dr. Spero Theodorou Will Represent InMode at 23rd Annual Needham & Company Virtual Healthcare Conference

InMode Ltd., a leading global provider of medical technologies, is all set to participate in the highly esteemed 23rd Annual Needham & Company Virtual Healthcare Conference on April 9, 2024. Representing InMode at this prestigious event is Dr. Spero Theodorou, M.D., the founder and Surgical Director of bodySCULPT®. Alongside Moshe Mizrahy, Chief Executive Officer and Chairman, and Yair Malca, Chief Financial Officer, Dr. Theodorou will engage in a virtual fireside chat moderated by Senior Equity Research Analyst Mike Matson, CFA. This discussion aims to explore InMode’s innovative technologies, strategic vision, financial performance, and plans for future growth. Additionally, the conference offers one-on-one meetings, providing attendees with direct access to InMode’s leadership team, fostering deeper insights into the company’s business model, product pipeline, and market positioning.

Featured in Luxury Magazine

We’re delighted to share that bodySCULPT and Aman New York have been spotlighted in a prestigious Luxury Magazine. Explore the exceptional offerings they provide and discover why Aman New York is highlighted as the best Banya in New York.

Dr Spero Theodorou, founder and Surgical Director of bodySCULPT, Presented at the 58th Annual Baker Gordon Symposium

Dr Spero Theodorou, representing bodySCULPT®, successfully concluded his participation in the 58th Annual Baker Gordon Symposium. On Thursday, February 9, 2024, Dr Theodorou spoke on the topic “Long Term Results with Radiofrequency – Primary Procedure, in Combination with Surgery and as an Aid for Revision Following Surgery”. Later on, on the same day, he presented a live demonstration, “Multimodal Radiofrequency for Facial Rejuvenation.” Renowned for its extensive history in aesthetic surgery education, this prestigious event provided a platform for Dr Theodorou to share his expertise in minimally invasive and non-invasive plastic surgery techniques. Held over three days from February 8 to 10, this year’s symposium featured live surgeries and lectures covering a diverse array of aesthetic and technical topics.

Dr. Spero Theodorou’s Recent Study Raises Safety Concerns about Dermal Fillers

Dr. Spero Theodorou, Founder and Surgical Director of bodySCULPT®, has presented a study that raises significant concerns about dermal fillers, emphasizing potential long-term issues and their impact on the immune system. His study reveals a link between dermal fillers and lymphatic blockages, which poses a threat to immune system functionality. Dr. Theodorou halted dermal filler offerings at his practice after finding that blocked lymphatics could compromise immune response. The study, presented at a plastic surgeons’ conference, utilized a SPY camera to track injected dye movement in lymphatic channels. Dr. Theodorou stresses the difficulty of complete filler removal, and the ethical responsibility to share the new findings. While Dr. Theodorou urges awareness, varying expert opinions add complexity to the safety debate.